This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Martin DDO , Kanuparthi PS , Holland SM , Sanders SS , Jeong HK , Einarson MB , Jacobson MA , Thomas GM
Identification of Novel Inhibitors of DLK Palmitoylation and Signaling by High Content Screening
Sci Rep. 2019 Mar 6;9(1) :3632
PMID: 30842471 PMCID: PMC6403299
AbstractAfter axonal insult and injury, Dual leucine-zipper kinase (DLK) conveys retrograde pro-degenerative signals to neuronal cell bodies via its downstream target c-Jun N-terminal kinase (JNK). We recently reported that such signals critically require modification of DLK by the fatty acid palmitate, via a process called palmitoylation. Compounds that inhibit DLK palmitoylation could thus reduce neurodegeneration, but identifying such inhibitors requires a suitable assay. Here we report that DLK subcellular localization in non-neuronal cells is highly palmitoylation-dependent and can thus serve as a proxy readout to identify inhibitors of DLK palmitoylation by High Content Screening (HCS). We optimized an HCS assay based on this readout, which showed highly robust performance in a 96-well format. Using this assay we screened a library of 1200 FDA-approved compounds and found that ketoconazole, the compound that most dramatically affected DLK localization in our primary screen, dose-dependently inhibited DLK palmitoylation in follow-up biochemical assays. Moreover, ketoconazole significantly blunted phosphorylation of c-Jun in primary sensory neurons subjected to trophic deprivation, a well known model of DLK-dependent pro-degenerative signaling. Our HCS platform is thus capable of identifying novel inhibitors of DLK palmitoylation and signalling that may have considerable therapeutic potential.
Notes2045-2322 Martin, Dale D O Kanuparthi, Prasad S Holland, Sabrina M Sanders, Shaun S Jeong, Hey-Kyeong Einarson, Margret B Jacobson, Marlene A Thomas, Gareth M R50 CA211479/U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01 NS094402/U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) Journal Article England Sci Rep. 2019 Mar 6;9(1):3632. doi: 10.1038/s41598-019-39968-8.